Effect of butylphthalide on the risk of post-stroke epilepsy in patients with cerebral infarction
10.12173/j.issn.1005-0698.202409037
- VernacularTitle:丁苯酞对脑梗死患者卒中后癫痫发病风险的影响
- Author:
Qi YU
1
;
Junfeng YUAN
;
Kai CHEN
;
Xiuyun LI
;
Zhanyong LI
Author Information
1. 廊坊市人民医院神经内科(河北廊坊 065000)
- Publication Type:Journal Article
- Keywords:
Butylphthalide;
Cerebral infarction;
Post-stroke epilepsy
- From:
Chinese Journal of Pharmacoepidemiology
2025;34(5):532-538
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of sequential therapy with butylphthalide on the risk of post-stroke epilepsy(PSE)in patients with cerebral infarction.Methods The clinical data of patients with cerebral infarction hospitalized in Langfang People's Hospital from October,2016 to October,2022 were selected and analyzed.Patients receiving butylphthalide sequential treatment were included in the butylphthalide group,patients who were hospitalized at the same time with matching gender,age(±5 years),basic disease,clinical drug treatment scheme and follow-up period but did not receive butylphthalide treatment were included in the control group.The general clinical data,laboratory examination results on admission,and incidence of PSE in the two groups were compared,and multivariate Logistic regression was used to analyze the correlation between sequential therapy with butylphthalide and PSE occurrence in patients with cerebral infarction.Results A total of 1,200 patients were included,with 600 patients in each group.There was no significant difference in general clinical data such as sex,age,complications and living habits between the two groups(P＞0.05).There were no significant differences between the two groups in the patients distribution of TOAST classification,NIHSS score(P＞0.05).The incidence of PSE in butylphthalide group was significantly lower than that in control group(4.17％vs.7.83％,P＜0.05).The application of sequential treatment with butylphthalide was a protective factor for PSE occurrence in patients with cerebral infarction[OR=0.352,95％CI(0.151,0.821),P=0.016].Conclusion Sequential treatment with butylphthalide can reduce the risk of post-stroke epilepsy in patients with cerebral infarction.
